Ambulance crews test Quick-Response blood clotting bundle for trauma patients
NCT ID NCT06891131
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a special combination of blood products and medication (fibrinogen, plasma, and tranexamic acid) can be given to trauma patients with life-threatening bleeding while still in the ambulance. The goal is to see if this approach is practical and safe. Only 10 adults with severe bleeding from injury will take part.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Fibrinogen, plasma, and tranexamic acid given as a transfusion bundle
- What this could lead to
- If successful, this could show that giving a specific combination of blood products and medication before reaching the hospital is feasible and may improve survival after severe bleeding.
- What could go wrong
- This is a very small, early feasibility study with only 10 participants. It is not designed to prove the treatment works, only that it can be given in an ambulance. Results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HAEMORRHAGIC SHOCK are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Medical University of Graz
RECRUITINGGraz, 8043, Austria
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.